Instrument Inactif

Communiqués Copper One Inc Toronto S.E.

Actions

CUO

CA21751Q2080

Equipement et technologie médicale avancés

Communiqués

31/08/24	Medivolve Announces Management Changes	AQ
13/02/24	Medivolve Announces Change of Auditor	AQ
16/01/24	Medivolve Announces Telehealth Platform Development Contract and Change of Officers and Directors	AQ
17/11/23	Medivolve Announces Change of Auditor and Board Changes	AQ
07/11/23	Medivolve Announces Board Changes	AQ
23/06/23	Medivolve Announces Results of Annual and Special Shareholder Meeting	AQ
16/05/23	Medivolve Achieves Significant Milestone by Establishing Management Services Organization	AQ
28/02/23	Medivolve to Host Live Webinar to Discuss Corporate Update	AQ
20/01/23	Medivolve Announces Private Placement Financing of up to $4 Million	GL
12/01/23	Medivolve Closes Previously Announced CAN $1.2 Million Convertible Note Financing	GL
24/12/22	Medivolve Announces CAN $1.2 Million Convertible Note Financing	GL
07/12/22	Medivolve to Implement Share Consolidation	AQ
15/11/22	Medivolve Announces Q3 2021 Results Reaches Record Levels of Revenue	AQ
15/11/22	Medivolve Pivoting Towards Expansion of Service Offerings and Other Updates	GL
27/09/22	Aberdeen Disposes of Shares of Medivolve and Ceases to Be an Insider	AQ
25/08/22	Medivolve Announces Launch of Investor Awareness Campaign and Refiling of Q2 2022 Financial Statements	AQ
16/08/22	Medivolve Announces Q2 2022 Financial Results	AQ
26/07/22	Medivolve Provides Update on its Mobile Clinic Network	AQ
17/06/22	Medivolve Announces Results of Annual and Special Shareholder Meeting	AQ
17/05/22	Medivolve Announces Q1 2022 Financial Results	AQ
03/05/22	Medivolve Announces Launch of Normal Course Issuer Bid	GL
06/04/22	Medivolve Welcomes Vincent Chen as VP of Corporate Development	AQ
05/04/22	Medivolve to Host Live Webinar to Discuss Corporate Update	GL
01/04/22	Medivolve Announces Q4 2021 Annual Results	GL
28/02/22	Medivolve Announces Appointment of Peter Michel as New Chief Financial Officer	AQ